D Budget

Sidebars: National Institutes of Health : Summary of Appropriations Research and Development Intestments Federal science and technology agencies are holding their own in President Clinton's recently proposed fiscal year 1998 budget, which allocates $75.5 billion-a 2.2 percent increase-to government-sponsored R&D. The National Institutes of Health and the National Science Foundation are slated to receive modest overall increases, approximately 2.6 percent and 3 percent, respectively. As the

Written bySteven Benowitz
| 11 min read

Register for free to listen to this article
Listen with Speechify
0:00
11:00
Share

Sidebars: National Institutes of Health : Summary of Appropriations
Research and Development Intestments


FRUSTRATED: NSF’s Neal Lane is glad his agency would receive a budget boost for FY 1998 but frustrated that the raise continues a flat spending trend.
"Last year's [budget] turbulence doesn't exist this year," says Rep. George E. Brown, Jr. (D-Calif.), ranking minority member of the House Science Committee, referring to the often rancorous FY 1997 budget discussions in Congress. "There's a general feeling that the R&D budget this year is much better than could have been expected."

The president's proposed 2.6 percent increase, or $337 million, for NIH would bring its budget to $13.1 billion, up from $12.7 billion in FY 1997. The NIH raise would support an additional 939 research grants and includes another $90 million installment for its 250-bed clinical center under construction. Under the proposal, NSF fared slightly better than NIH. The agency's ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies